BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,362,978 | -18.7% | 1,890,884 | -1.8% | 0.05% | -14.5% |
| Q2 2023 | $87,755,569 | +2689.7% | 1,926,162 | +2383.3% | 0.06% | +2650.0% |
| Q1 2023 | $3,145,665 | -72.2% | 77,565 | -65.0% | 0.00% | -75.0% |
| Q4 2022 | $11,295,960 | +267.6% | 221,614 | +94.7% | 0.01% | +300.0% |
| Q3 2022 | $3,073,070 | -19.4% | 113,796 | +91.7% | 0.00% | -33.3% |
| Q2 2022 | $3,814,000 | -76.6% | 59,368 | -71.8% | 0.00% | -62.5% |
| Q1 2022 | $16,333,000 | +47.6% | 210,632 | +63.4% | 0.01% | +60.0% |
| Q4 2021 | $11,068,000 | -65.3% | 128,943 | -67.5% | 0.01% | -64.3% |
| Q3 2021 | $31,877,000 | -67.0% | 396,353 | -67.0% | 0.01% | -65.9% |
| Q2 2021 | $96,667,000 | -20.2% | 1,200,842 | -16.4% | 0.04% | -25.5% |
| Q1 2021 | $121,166,000 | -15.4% | 1,436,625 | -19.5% | 0.06% | -17.9% |
| Q4 2020 | $143,191,000 | -6.9% | 1,784,570 | -6.7% | 0.07% | -16.2% |
| Q3 2020 | $153,786,000 | -7.7% | 1,912,292 | -1.2% | 0.08% | -14.9% |
| Q2 2020 | $166,678,000 | -5.8% | 1,935,905 | -11.2% | 0.09% | -23.0% |
| Q1 2020 | $176,944,000 | -19.9% | 2,179,535 | -17.5% | 0.12% | +8.0% |
| Q4 2019 | $220,820,000 | -25.9% | 2,640,819 | -22.4% | 0.11% | -29.8% |
| Q3 2019 | $297,856,000 | -12.4% | 3,405,283 | -18.0% | 0.16% | -13.0% |
| Q2 2019 | $340,206,000 | -3.6% | 4,153,946 | -4.3% | 0.18% | -5.6% |
| Q1 2019 | $352,990,000 | +11.3% | 4,341,259 | -9.9% | 0.20% | -3.0% |
| Q4 2018 | $317,028,000 | -4.8% | 4,816,565 | +11.5% | 0.20% | +13.5% |
| Q3 2018 | $333,116,000 | +12.4% | 4,321,125 | +7.6% | 0.18% | +5.3% |
| Q2 2018 | $296,424,000 | +9.1% | 4,014,411 | -3.9% | 0.17% | +5.6% |
| Q1 2018 | $271,644,000 | -0.7% | 4,176,540 | -1.4% | 0.16% | -5.3% |
| Q4 2017 | $273,694,000 | +12.5% | 4,234,117 | +9.2% | 0.17% | +8.3% |
| Q3 2017 | $243,337,000 | +22.2% | 3,877,889 | +17.9% | 0.16% | +15.6% |
| Q2 2017 | $199,140,000 | +5672.2% | 3,289,402 | +4844.6% | 0.14% | +462.5% |
| Q1 2017 | $3,450,000 | +18.5% | 66,525 | +1.4% | 0.02% | +14.3% |
| Q4 2016 | $2,911,000 | +3.4% | 65,625 | +11.0% | 0.02% | 0.0% |
| Q3 2016 | $2,814,000 | -11.1% | 59,125 | -15.5% | 0.02% | -19.2% |
| Q2 2016 | $3,165,000 | +6.0% | 70,001 | -3.6% | 0.03% | +8.3% |
| Q1 2016 | $2,985,000 | +7.8% | 72,629 | 0.0% | 0.02% | +9.1% |
| Q4 2015 | $2,770,000 | +16.1% | 72,629 | 0.0% | 0.02% | +4.8% |
| Q3 2015 | $2,386,000 | -90.8% | 72,629 | -80.3% | 0.02% | -89.7% |
| Q2 2015 | $25,802,000 | -2.4% | 369,157 | -4.4% | 0.20% | -0.5% |
| Q1 2015 | $26,447,000 | -23.3% | 386,165 | -17.9% | 0.20% | -18.1% |
| Q4 2014 | $34,476,000 | +2.8% | 470,338 | +0.6% | 0.25% | -21.0% |
| Q3 2014 | $33,538,000 | +12.6% | 467,460 | +13.5% | 0.32% | +13.3% |
| Q2 2014 | $29,779,000 | +65.1% | 411,964 | +68.1% | 0.28% | +58.0% |
| Q1 2014 | $18,032,000 | +4.4% | 245,030 | -1.3% | 0.18% | +1.1% |
| Q4 2013 | $17,265,000 | +11.4% | 248,251 | +5.2% | 0.17% | +1.8% |
| Q3 2013 | $15,493,000 | +8.8% | 235,871 | +16.0% | 0.17% | +2.4% |
| Q2 2013 | $14,245,000 | – | 203,357 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |